CLINICAL_TRIALS
trial_result
· 2013-09-23
Clinical Trial Update: ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) [Phase 4]
Summary
Phase 4 study evaluating safety and immunogenicity of ZOSTAVAX in Korean adults completed. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster, Shingles | Phase 4 | Status: COMPLETED | Results posted: 2013-09-23